Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telaprevir vs PR in HCV Genotype 1 IL28B CC
NCT01415141Phase 4Withdrawn
- Sponsor
- The University of Vermont
- Start
- Jul 2011
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of telaprevir in hepatitis C virus infection, sponsored by The University of Vermont. Planned start Jul 2011; status: withdrawn.
02
Drugs
telaprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT01415141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01415141.